In the BioHarmony Drug Report Database
Methoxsalen
8-mop, Oxsoralen, Oxsoralen-ultra, Uvadex (methoxsalen) is a small molecule pharmaceutical. Methoxsalen was first approved as 8-mop on 1982-01-01. It is used to treat mycosis fungoides, psoriasis, and vitiligo in the USA.
Trade Name
|
8-mop, Oxsoralen, Oxsoralen-ultra, Uvadex |
|---|---|
Common Name
|
methoxsalen |
ChEMBL ID
|
CHEMBL416 |
Indication
|
mycosis fungoides, psoriasis, vitiligo |
Drug Class
|
Anti-inflammatory agents (salicylic acid derivatives) |
Image (chem structure or protein)